Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuankai Shi

Showing results (41-50 of 347) with videos related to

Pageof 35
Sort By:
Journal of Cancer|January 4, 2021
Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysisYu Zhou, Haizhu Chen, Yunxia Tao, et al.
Journal of Neuro-Oncology|September 4, 2013
Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patientsChunxia Du, Ruoxi Hong, Yuankai Shi, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 19, 2015
[Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases]Jianping Xu, Xiaoyan Liu, Sheng Yang, et al.
Asia-Pacific Journal of Clinical Oncology|December 16, 2017
Clinical response to apatinib monotherapy in advanced non-small cell lung cancerJianping Xu, Xiaoyan Liu, Sheng Yang, et al.
NPJ Precision Oncology|January 16, 2026
Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancerTongji Xie, Le Tang, Guangyu Fan, et al.
Thoracic Cancer|September 9, 2022
The exploration of three different treatment models of osimertinib plus antiangiogenic agents in non-small cell lung cancer: A real-world studyYu Feng, Liling Huang, Haohua Zhu, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 2022
Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysisHaizhu Chen, Yu Feng, Yu Zhou, et al.
Cancer Immunology, Immunotherapy : CII|July 17, 2023
Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencingLiling Huang, Ning Lou, Tongji Xie, et al.
Clinical Biochemistry|February 23, 2020
Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancerShuxia Liu, Minjie Wang, Cuiling Zheng, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2020
Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysisHaizhu Chen, Daquan Wang, Qiaofeng Zhong, et al.
Pageof 35

Showing results (41-50 of 347) with videos related to

Sort By:
Pageof 35
Journal of Cancer|January 4, 2021
Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysisYu Zhou, Haizhu Chen, Yunxia Tao, et al.
Journal of Neuro-Oncology|September 4, 2013
Leptomeningeal metastasis from solid tumors: a single center experience in Chinese patientsChunxia Du, Ruoxi Hong, Yuankai Shi, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 19, 2015
[Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases]Jianping Xu, Xiaoyan Liu, Sheng Yang, et al.
Asia-Pacific Journal of Clinical Oncology|December 16, 2017
Clinical response to apatinib monotherapy in advanced non-small cell lung cancerJianping Xu, Xiaoyan Liu, Sheng Yang, et al.
NPJ Precision Oncology|January 16, 2026
Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancerTongji Xie, Le Tang, Guangyu Fan, et al.
Thoracic Cancer|September 9, 2022
The exploration of three different treatment models of osimertinib plus antiangiogenic agents in non-small cell lung cancer: A real-world studyYu Feng, Liling Huang, Haohua Zhu, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 2022
Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysisHaizhu Chen, Yu Feng, Yu Zhou, et al.
Cancer Immunology, Immunotherapy : CII|July 17, 2023
Identification of an antigen-presenting cells/T/NK cells-related gene signature to predict prognosis and CTSL to predict immunotherapeutic response for lung adenocarcinoma: an integrated analysis of bulk and single-cell RNA sequencingLiling Huang, Ning Lou, Tongji Xie, et al.
Clinical Biochemistry|February 23, 2020
Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancerShuxia Liu, Minjie Wang, Cuiling Zheng, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2020
Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysisHaizhu Chen, Daquan Wang, Qiaofeng Zhong, et al.
Pageof 35